These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 19656639)
1. Clinically important interaction between statin drugs and Clostridium difficile toxin? McGuire T; Dobesh P; Klepser D; Rupp M; Olsen K Med Hypotheses; 2009 Dec; 73(6):1045-7. PubMed ID: 19656639 [TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile toxins: more than mere inhibitors of Rho proteins. Genth H; Dreger SC; Huelsenbeck J; Just I Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919 [TBL] [Abstract][Full Text] [Related]
3. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Aseeri M; Schroeder T; Kramer J; Zackula R Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653 [TBL] [Abstract][Full Text] [Related]
4. Surveillance for community-associated Clostridium difficile--Connecticut, 2006. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(13):340-3. PubMed ID: 18385641 [TBL] [Abstract][Full Text] [Related]
5. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea. Jiang ZD; Garey KW; Price M; Graham G; Okhuysen P; Dao-Tran T; LaRocco M; DuPont HL Clin Gastroenterol Hepatol; 2007 Aug; 5(8):964-8. PubMed ID: 17618838 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical features of Clostridium difficile-associated diarrhea in a tertiary hospital in northern Taiwan. Hsu MS; Wang JT; Huang WK; Liu YC; Chang SC J Microbiol Immunol Infect; 2006 Jun; 39(3):242-8. PubMed ID: 16783456 [TBL] [Abstract][Full Text] [Related]
7. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors]. Tunçcan OG; Ulutan F; Karakuş R Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078 [TBL] [Abstract][Full Text] [Related]
8. [Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina]. Fernandez Canigia L; Nazar J; Arce M; Dadamio J; Smayevsky J; Bianchini H Rev Argent Microbiol; 2001; 33(2):101-7. PubMed ID: 11494752 [TBL] [Abstract][Full Text] [Related]
9. A study of Clostridium difficile-associated disease at King Chulalongkorn Memorial Hospital, Thailand. Pupaibool J; Khantipong M; Suankratay C J Med Assoc Thai; 2008 Jan; 91(1):37-43. PubMed ID: 18386542 [TBL] [Abstract][Full Text] [Related]
10. Emergence of Clostridium difficile-associated disease in North America and Europe. Kuijper EJ; Coignard B; Tüll P; ; ; Clin Microbiol Infect; 2006 Oct; 12 Suppl 6():2-18. PubMed ID: 16965399 [TBL] [Abstract][Full Text] [Related]
11. Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation. Vesta KS; Wells PG; Gentry CA; Stipek WJ Am J Infect Control; 2005 Oct; 33(8):469-72. PubMed ID: 16216661 [TBL] [Abstract][Full Text] [Related]
12. [Clostridium difficile toxin A and other enteropathogens in stool specimens of children hospitalized due to acute diarrhoea]. Rozkiewicz D; Zaremba ML; Fiedoruk K; Daniluk T; Sciepuk M; Kurzatkowska B; Sulik A; Ołdak E Przegl Epidemiol; 2005; 59(3):711-21. PubMed ID: 16433313 [TBL] [Abstract][Full Text] [Related]
13. Established and potential risk factors for Clostridum difficile infection. Vaishnavi C Indian J Med Microbiol; 2009; 27(4):289-300. PubMed ID: 19736396 [TBL] [Abstract][Full Text] [Related]
14. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Pépin J; Saheb N; Coulombe MA; Alary ME; Corriveau MP; Authier S; Leblanc M; Rivard G; Bettez M; Primeau V; Nguyen M; Jacob CE; Lanthier L Clin Infect Dis; 2005 Nov; 41(9):1254-60. PubMed ID: 16206099 [TBL] [Abstract][Full Text] [Related]
15. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Arango JI; Restrepo A; Schneider DL; Callander NS; Ochoa-Bayona JL; Restrepo MI; Bradshaw P; Patterson J; Freytes CO Bone Marrow Transplant; 2006 Mar; 37(5):517-21. PubMed ID: 16435018 [TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile-associated diarrhoea in patients with human immunodeficiency virus infection: a case-control study. Tumbarello M; Tacconelli E; Leone F; Cauda R; Ortona L Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):259-63. PubMed ID: 7743309 [TBL] [Abstract][Full Text] [Related]
18. Do statins protect against the development of Clostridium difficile-associated diarrhoea? Nseir W; Bishara J; Mograbi J; Mahamid M; Khalaila W; Taha M; Farah R J Antimicrob Chemother; 2013 Aug; 68(8):1889-93. PubMed ID: 23563740 [TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics. Gursoy S; Guven K; Arikan T; Yurci A; Torun E; Baskol M; Ozbakir O; Yucesoy M Hepatogastroenterology; 2007 Sep; 54(78):1720-4. PubMed ID: 18019703 [TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer? Muñoz P; Giannella M; Alcalá L; Sarmiento E; Fernandez Yañez J; Palomo J; Catalán P; Carbone J; Bouza E J Heart Lung Transplant; 2007 Sep; 26(9):907-14. PubMed ID: 17845929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]